Takeda sells select non-core assets in Europe to Cheplapharm for about $562 mn
Portfolio includes prescription products in Takeda’s cardiovascular/metabolic and anti-inflammatory therapeutic areas along with…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.